Omid Farokhzad
Omid Farokhzad
Senior Lecturer (Previously Professor), Brigham & Women's Hospital and Harvard Medical School, USA
Verified email at - Homepage
Cited by
Cited by
Nanocarriers as an emerging platform for cancer therapy
D Peer, JM Karp, S Hong, OC Farokhzad, R Margalit, R Langer
Nano-enabled medical applications, 61-91, 2020
Cancer nanomedicine: progress, challenges and opportunities
J Shi, PW Kantoff, R Wooster, OC Farokhzad
Nature reviews cancer 17 (1), 20-37, 2017
Factors affecting the clearance and biodistribution of polymeric nanoparticles
F Alexis, E Pridgen, LK Molnar, OC Farokhzad
Molecular pharmaceutics 5 (4), 505-515, 2008
Impact of nanotechnology on drug delivery
OC Farokhzad, R Langer
ACS nano 3 (1), 16-20, 2009
Nanoparticles in medicine: therapeutic applications and developments
L Zhang, FX Gu, JM Chan, AZ Wang, RS Langer, OC Farokhzad
Clinical pharmacology & therapeutics 83 (5), 761-769, 2008
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology
N Bertrand, J Wu, X Xu, N Kamaly, OC Farokhzad
Advanced drug delivery reviews 66, 2-25, 2014
Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release
N Kamaly, B Yameen, J Wu, OC Farokhzad
Chemical reviews 116 (4), 2602-2663, 2016
Cellular uptake of nanoparticles: journey inside the cell
S Behzadi, V Serpooshan, W Tao, MA Hamaly, MY Alkawareek, ...
Chemical society reviews 46 (14), 4218-4244, 2017
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
OC Farokhzad, J Cheng, BA Teply, I Sherifi, S Jon, PW Kantoff, JP Richie, ...
Proceedings of the National Academy of Sciences 103 (16), 6315-6320, 2006
Nanotechnology in drug delivery and tissue engineering: from discovery to applications
J Shi, AR Votruba, OC Farokhzad, R Langer
Nano letters 10 (9), 3223-3230, 2010
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
N Kamaly, Z Xiao, PM Valencia, AF Radovic-Moreno, OC Farokhzad
Chemical Society Reviews 41 (7), 2971-3010, 2012
Nanoparticle delivery of cancer drugs
AZ Wang, R Langer, OC Farokhzad
Annual review of medicine 63, 185-198, 2012
Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery
J Cheng, BA Teply, I Sherifi, J Sung, G Luther, FX Gu, ...
Biomaterials 28 (5), 869-876, 2007
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology
U Prabhakar, H Maeda, RK Jain, EM Sevick-Muraca, W Zamboni, ...
Cancer research 73 (8), 2412-2417, 2013
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells
OC Farokhzad, S Jon, A Khademhosseini, TNT Tran, DA LaVan, ...
Cancer research 64 (21), 7668-7672, 2004
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile
J Hrkach, D Von Hoff, MM Ali, E Andrianova, J Auer, T Campbell, ...
Science translational medicine 4 (128), 128ra39-128ra39, 2012
Quantum dot− aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer
V Bagalkot, L Zhang, E Levy-Nissenbaum, S Jon, PW Kantoff, R Langer, ...
Nano letters 7 (10), 3065-3070, 2007
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA–PEG nanoparticles
S Dhar, FX Gu, R Langer, OC Farokhzad, SJ Lippard
Proceedings of the National Academy of Sciences 105 (45), 17356-17361, 2008
Self-assembled lipid− polymer hybrid nanoparticles: a robust drug delivery platform
L Zhang, JM Chan, FX Gu, JW Rhee, AZ Wang, AF Radovic-Moreno, ...
ACS nano 2 (8), 1696-1702, 2008
Nanomedicine: developing smarter therapeutic and diagnostic modalities
OC Farokhzad, R Langer
Advanced drug delivery reviews 58 (14), 1456-1459, 2006
The system can't perform the operation now. Try again later.
Articles 1–20